Medical Properties Trust, Inc. (MPW) Q3 2022 Earnings Call Transcript

SA Transcripts
153.96K Followers

Q3: 2022-10-27 Earnings Summary

EPS of $0.37 beats by $0.07
 | Revenue of $352.34M (-9.84% Y/Y) misses by $36.68M

Medical Properties Trust, Inc. (NYSE:MPW) Q3 2022 Earnings Conference Call October 27, 2022 11:00 AM ET

Company Participants

Charles Lambert - Vice President & Treasurer
Edward K. Aldag - Chairman, President & Chief Executive Officer
Steven Hamner - Executive Vice President & Chief Financial Officer

Conference Call Participants

Vikram Malhotra - Mizuho
Jonathan Hughes - Raymond James
Michael Carroll - RBC Capital Markets
John Pawlowski - Green Street
Steven Valiquette - Barclays
Mike Muller - JPMorgan
Joshua Dennerlein - Bank of America
Tayo Okusanya - Credit Suisse

Operator

Good day, and welcome to the Third Quarter 2022 Medical Properties Trust's Earnings Conference Call. All participants will be in listen-only mode. [Operator Instructions] Today's call will last one hour and after today's presentation, there will be an opportunity to ask questions. Please note, this event is being recorded.

I would now like to turn the conference back over to Charles Lambert. Please go ahead.

Charles Lambert

Good morning. Welcome to the Medical Properties Trust conference call to discuss our third quarter 2022 financial results. With me today are Edward K. Aldag, Jr., Chairman, President and Chief Executive Officer of the company; and Steven Hamner, Executive Vice President and Chief Financial Officer.

Our press release was distributed this morning and furnished on Form 8-K with the Securities and Exchange Commission. If you did not receive a copy, it is available on our website at www.medicalpropertiestrust.com in the Investor Relations section. Additionally, we’re hosting a live webcast of today's call, which you can access in that same section.

During the course of this call, we will make projections and certain other statements that may be considered forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are subject to known and unknown risks, uncertainties and other factors that may

Recommended For You

About MPW Stock

SymbolLast Price% Chg
EPS
PE
Div Rate
Yield
Short Interest
Market Cap
Volume
Compare to Peers

More on MPW